Literature DB >> 10712670

CXC chemokine receptor 4 expression and stromal cell-derived factor-1alpha-induced chemotaxis in CD4+ T lymphocytes are regulated by interleukin-4 and interleukin-10.

T Jinquan1, S Quan, H H Jacobi, H O Madsen, C Glue, P S Skov, H J Malling, L K Poulsen.   

Abstract

We report that interleukin (IL)-4 and IL-10 can significantly up- or down-regulate CXC chemokine receptor 4 (CXCR4) expression on CD4+ T lymphocytes, respectively. Stromal cell-derived factor-1alpha (SDF-1alpha)-induced CD4+ T-lymphocyte chemotaxis was also correspondingly regulated by IL-4 and IL-10. IL-4 and IL-10 up- or down-regulated CXCR4 mRNA expression in CD4+ T lymphocytes, respectively, as detected by real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR). Scatchard analysis revealed a type of CXCR4 with affinity (Kd approximately 6.3 nM), and approximately 70,000 SDF-1alpha-binding sites per cell, among freshly isolated CD4+ T lymphocytes, and two types of CXCR4 with different affinities (Kd1 approximately 4.4 nM and Kd2 approximately 14.6 nM), and a total of approximately 130,000 SDF-1alpha-binding sites per cell, among IL-4-stimulated CD4+ T lymphocytes. The regulation of CXCR4 expression in CD4+ T lymphocytes by IL-4 and IL-10 could be blocked by a selective inhibitor of protein kinase (staurosporine) or by a selective inhibitor of cAMP- and cGMP-dependent protein kinase (H-8), indicating that these cytokines regulate CXCR4 on CD4+ T lymphocytes via both cAMP and cGMP signalling pathways. The fact that cyclosporin A or ionomycin were able to independently change the CXCR4 expression and block the effects of IL-4 and IL-10 on CXCR4 expression implied that the capacity of IL-4 and IL-10 to regulate CXCR4 on CD4+ T lymphocytes is not linked to calcium-mobilization stimulation. These results indicate that the effects of IL-4 and IL-10 on the CXCR4-SDF-1 receptor-ligand pair may be of particular importance in the cytokine/chemokine environment concerning the inflammatory processes and in the progression of human immunodeficiency virus (HIV) infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712670      PMCID: PMC2327181          DOI: 10.1046/j.1365-2567.2000.00954.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression.

Authors:  A Valentin; W Lu; M Rosati; R Schneider; J Albert; A Karlsson; G N Pavlakis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

2.  T134, a small-molecule CXCR4 inhibitor, has no cross-drug resistance with AMD3100, a CXCR4 antagonist with a different structure.

Authors:  R Arakaki; H Tamamura; M Premanathan; K Kanbara; S Ramanan; K Mochizuki; M Baba; N Fujii; H Nakashima
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

Review 3.  Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses.

Authors:  F Sallusto; A Lanzavecchia; C R Mackay
Journal:  Immunol Today       Date:  1998-12

4.  Staurosporine, a protein kinase C inhibitor interferes with proliferation of arterial smooth muscle cells.

Authors:  H Matsumoto; Y Sasaki
Journal:  Biochem Biophys Res Commun       Date:  1989-01-16       Impact factor: 3.575

5.  Potentiation of the adrenergic beta-receptor-mediated insulin secretion in pertussis-sensitized rats.

Authors:  T Sumi; M Ui
Journal:  Endocrinology       Date:  1975-08       Impact factor: 4.736

6.  Effect of the protein kinase inhibitors, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine H-7 and N-(2-[methylamino]ethyl)-5-isoquinoline-sulfonamide H-8 on Lewis lung carcinoma tumor progression.

Authors:  C Blaya; J Crespo; A Crespo; S F Aliño
Journal:  Eur J Pharmacol       Date:  1998-07-31       Impact factor: 4.432

7.  IL-4 and a glucocorticoid up-regulate CXCR4 expression on human CD4+ T lymphocytes and enhance HIV-1 replication.

Authors:  J Wang; A Harada; S Matsushita; S Matsumi; Y Zhang; T Shioda; Y Nagai; K Matsushima
Journal:  J Leukoc Biol       Date:  1998-11       Impact factor: 4.962

8.  Enhanced HIV expression during Th2-oriented responses explained by the opposite regulatory effect of IL-4 and IFN-gamma of fusin/CXCR4.

Authors:  G Galli; F Annunziato; C Mavilia; P Romagnani; L Cosmi; R Manetti; C Pupilli; E Maggi; S Romagnani
Journal:  Eur J Immunol       Date:  1998-10       Impact factor: 5.532

9.  Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression.

Authors:  J Wang; G Roderiquez; T Oravecz; M A Norcross
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

10.  Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines.

Authors:  C Feil; H G Augustin
Journal:  Biochem Biophys Res Commun       Date:  1998-06-09       Impact factor: 3.575

View more
  16 in total

1.  Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?

Authors:  M A Martins; M L Silva; A P V Marciano; V Peruhype-Magalhães; S M Eloi-Santos; j G L Ribeiro; R Correa-Oliveira; A Homma; E G Kroon; A Teixeira-Carvalho; O A Martins-Filho
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

Review 2.  Genetic networks in osseointegration.

Authors:  I Nishimura
Journal:  J Dent Res       Date:  2013-10-24       Impact factor: 6.116

3.  The CXCR4/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes.

Authors:  E Aboumrad; A M Madec; C Thivolet
Journal:  Clin Exp Immunol       Date:  2007-03-21       Impact factor: 4.330

Review 4.  Current status of interleukin-10 and regulatory T-cells in cancer.

Authors:  Kristen L Dennis; Nichole R Blatner; Fotini Gounari; Khashayarsha Khazaie
Journal:  Curr Opin Oncol       Date:  2013-11       Impact factor: 3.645

5.  Effects of CXCR4 gene silencing by lentivirus shRNA on proliferation of the EC9706 human esophageal carcinoma cell line.

Authors:  Dao-feng Wang; Ning Lou; Miao-zhen Qiu; Yong-bin Lin; Ying Liang
Journal:  Tumour Biol       Date:  2013-06-07

6.  Interleukin 10 mediated by herpes simplex virus vectors suppresses neuropathic pain induced by human immunodeficiency virus gp120 in rats.

Authors:  Wenwen Zheng; Wan Huang; Shue Liu; Roy C Levitt; Keith A Candiotti; David A Lubarsky; Shuanglin Hao
Journal:  Anesth Analg       Date:  2014-09       Impact factor: 5.108

7.  CXCR4 is down-regulated in cells infected with the CD4-independent X4 human immunodeficiency virus type 1 isolate m7NDK.

Authors:  S T Valente; C Chanel; J Dumonceaux; R Olivier; S Marullo; P Briand; U Hazan
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

8.  Transforming growth factor-beta1 upregulates the expression of CXC chemokine receptor 4 (CXCR4) in human breast cancer MCF-7 cells.

Authors:  Xiao-ping Zhao; Yong-yao Huang; Yu Huang; Ping Lei; Ji-lin Peng; Sha Wu; Min Wang; Wen-han Li; Hui-fen Zhu; Guan-xin Shen
Journal:  Acta Pharmacol Sin       Date:  2010-02-15       Impact factor: 6.150

9.  T cell activation by soluble C1q-bearing immune complexes: implications for the pathogenesis of rheumatoid arthritis.

Authors:  K Jiang; Y Chen; C-S Xu; J N Jarvis
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

10.  Peripheral blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection.

Authors:  Annie Gosselin; Patricia Monteiro; Nicolas Chomont; Felipe Diaz-Griffero; Elias A Said; Simone Fonseca; Vanessa Wacleche; Mohamed El-Far; Mohamed-Rachid Boulassel; Jean-Pierre Routy; Rafick-Pierre Sekaly; Petronela Ancuta
Journal:  J Immunol       Date:  2009-12-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.